Hound Partners’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-4,667
Closed -$1.09M 145
2020
Q3
$1.09M Buy
+4,667
New +$1.17M 0.07% 84

Other funds holding FRLN

Hound Partners's FRLN Position: Q4 2020 in Review

Hound Partners sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q4 2020, closing a stake of 4,667 shares — an estimated $1.09M sold.

Hound Partners first reported a position in FRLN in Q3 2020 and held it in 1 quarter. The position peaked at $1.09M in Q3 2020. 20 funds tracked by Wall St. Rank hold FRLN as of Q4 2020.

  • Hound Partners reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Hound Partners sold 4,667 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q4 2020, an estimated $1.09M.
  • Hound Partners first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and held it in 1 quarter.
  • Hound Partners's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $1.09M in Q3 2020.
  • 20 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q4 2020.

Based on Hound Partners's 13F filing for Q4 2020, filed 16 Feb 2021.